Human Genome Epidemiology Literature Finder
|
Records 1 - 22 (of 22 Records) |
| Query Trace: Neoplasms and AREG[original query] |
|---|
| Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Oct 27 (30): 5068-74. Jacobs Bart, De Roock Wendy, Piessevaux Hubert, Van Oirbeek Robin, Biesmans Bart, De Schutter Jef, Fieuws Steffen, Vandesompele Jo, Peeters Marc, Van Laethem Jean-Luc, Humblet Yves, Pénault-Llorca Frederique, De Hertogh Gert, Laurent-Puig Pierre, Van Cutsem Eric, Tejpar Sabi |
| Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in = 2 line cetuximab-based therapy of colorectal cancer patients. PloS one 2011 6 (1): e15980. Saridaki Zacharenia, Tzardi Maria, Papadaki Chara, Sfakianaki Maria, Pega Fraga, Kalikaki Aristea, Tsakalaki Eleftheria, Trypaki Maria, Messaritakis Ippokratis, Stathopoulos Efstathios, Mavroudis Dimitris, Georgoulias Vassilis, Souglakos Jo |
Genetic variants associated with breast size also influence breast cancer risk.
BMC medical genetics 2012 13 (1): 53. Eriksson Nicholas, Benton Geoffrey M, Do Chuong B, Kiefer Amy K, Mountain Joanna L, Hinds David A, Francke Uta, Tung Joyce |
| Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan. The pharmacogenomics journal 2014 Jun 14 (3): 256-62. Sebio A, Páez D, Salazar J, Berenguer-Llergo A, Paré-Brunet L, Lasa A, Del Río E, Tobeña M, Martín-Richard M, Baiget M, Barnadas |
| Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. BMC cancer 2013 Feb 13 (1): 1. Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G |
| Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. Pharmacogenetics and genomics 2014 Nov 24 (11): 539-47. Wakatsuki Takeru, Stintzing Sebastian, Zhang Wu, Yang Dongyun, Azuma Mizutomo, Ning Yan, Yamauchi Shinichi, Matsusaka Satoshi, Volz Nico B, Sunakawa Yu, Koizumi Wasaburo, Watanabe Masahiko, Barzi Afsaneh, El Khoueiry Anthony B, Shah Manish A, Lenz Heinz-Jos |
| EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer. The pharmacogenomics journal 2015 Feb 15 (1): 77-83. Sebio A, Salazar J, Páez D, Berenguer-Llergo A, Del Río E, Tobeña M, Martín-Richard M, Sullivan I, Targarona E, Balart J, Baiget M, Barnadas |
| Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.
Nature communications 2014 5 5303. Lindström Sara, Thompson Deborah J, Paterson Andrew D, Li Jingmei, Gierach Gretchen L, Scott Christopher, Stone Jennifer, Douglas Julie A, dos-Santos-Silva Isabel, Fernandez-Navarro Pablo, Verghase Jajini, Smith Paula, Brown Judith, Luben Robert, Wareham Nicholas J, Loos Ruth J F, Heit John A, Pankratz V Shane, Norman Aaron, Goode Ellen L, Cunningham Julie M, deAndrade Mariza, Vierkant Robert A, Czene Kamila, Fasching Peter A, Baglietto Laura, Southey Melissa C, Giles Graham G, Shah Kaanan P, Chan Heang-Ping, Helvie Mark A, Beck Andrew H, Knoblauch Nicholas W, Hazra Aditi, Hunter David J, Kraft Peter, Pollan Marina, Figueroa Jonine D, Couch Fergus J, Hopper John L, Hall Per, Easton Douglas F, Boyd Norman F, Vachon Celine M, Tamimi Rulla |
| Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy. Molecular diagnosis & therapy 2015 Sep . Llovet Patricia, Sastre Javier, Ortega Julián Sanz, Bando Inmaculada, Ferrer Milagros, García-Alfonso Pilar, Donnay Olga, Carrato Alfredo, Jiménez Ana, Aranda Enrique, León Ana, Grávalos Cristina, Cámara Juan Carlos, Feliú Jaime, Sanchíz Bárbara, Caldés Trinidad, Díaz-Rubio Eduar |
| A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast cancer research : BCR 2015 17 (1): 110. Rudolph Anja, Fasching Peter A, Behrens Sabine, Eilber Ursula, Bolla Manjeet K, Wang Qin, Thompson Deborah, Czene Kamila, Brand Judith S, Li Jingmei, Scott Christopher, Pankratz V Shane, Brandt Kathleen, Hallberg Emily, Olson Janet E, Lee Adam, Beckmann Matthias W, Ekici Arif B, Haeberle Lothar, Maskarinec Gertraud, Le Marchand Loic, Schumacher Fredrick, Milne Roger L, Knight Julia A, Apicella Carmel, Southey Melissa C, Kapuscinski Miroslav K, Hopper John L, Andrulis Irene L, Giles Graham G, Haiman Christopher A, Khaw Kay-Tee, Luben Robert, Hall Per, Pharoah Paul D P, Couch Fergus J, Easton Douglas F, Dos-Santos-Silva Isabel, Vachon Celine, Chang-Claude Jen |
| Identification of two novel mammographic density loci at 6Q25.1. Breast cancer research : BCR 2015 17 (1): 75. Brand Judith S, Li Jingmei, Humphreys Keith, Karlsson Robert, Eriksson Mikael, Ivansson Emma, Hall Per, Czene Kami |
| Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations. Translational oncology 2016 Aug 9 (4): 306-12. Sandfeld-Paulsen Birgitte, Folkersen Birgitte Holst, Rasmussen Torben Riis, Meldgaard Peter, Sorensen Boe |
| Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. British journal of cancer 2016 Jun 114 (12): 1352-1361. Lee Michael S, McGuffey Elizabeth J, Morris Jeffrey S, Manyam Ganiraju, Baladandayuthapani Veerabahdran, Wei Wei, Morris Van K, Overman Michael J, Maru Dipen M, Jiang Zhi-Qin, Hamilton Stanley R, Kopetz Sco |
| Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Cancer biology & therapy 2016 Apr 0. Sunakawa Yu, Yang Dongyun, Moran Miriana, Astrow Stephanie H, Tsuji Akihito, Stephens Craig, Zhang Wu, Cao Shu, Takahashi Takehiro, Denda Tadamichi, Shimada Ken, Kochi Mitsugu, Nakamura Masato, Kotaka Masahito, Segawa Yoshihiko, Masuishi Toshiki, Takeuchi Masahiro, Fujii Masashi, Nakajima Toshifusa, Ichikawa Wataru, Lenz Heinz-Jos |
| Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women. Nature communications 2017 Nov 8 (1): 1632. Kadalayil Latha, Khan Sofia, Nevanlinna Heli, Fasching Peter A, Couch Fergus J, Hopper John L, Liu Jianjun, Maishman Tom, Durcan Lorraine, Gerty Sue, Blomqvist Carl, Rack Brigitte, Janni Wolfgang, Collins Andrew, Eccles Diana, Tapper Willi |
| Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer. JAMA oncology 2017 Oct . Seligmann Jenny F, Hatch Ace J, Richman Susan D, Elliott Faye, Jacobs Bart, Brown Sarah, Hurwitz Herbert, Barrett Jennifer H, Quirke Philip, Nixon Andrew B, Seymour Matthew |
| Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial. Acta oncologica (Stockholm, Sweden) 2018 May 1-6. Brøndum Line, Alsner Jan, Sørensen Brita Singers, Maare Christian, Johansen Jørgen, Primdahl Hanne, Evensen Jan Folkvard, Kristensen Claus Andrup, Andersen Lisbeth Juhler, Overgaard Jens, Eriksen Jesper Gr |
| Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Mar . Hill Andrew G, Findlay Michael P, Burge Matthew E, Jackson Christopher, Alfonso Pilar Garcia, Samuel Leslie, Ganju Vinod, Karthaus Meinolf, Amatu Alessio, Jeffery Mark, Bartolomeo Maria Di, Bridgewater John, Coveler Andrew L, Hidalgo Manuel, Kapp Amy V, Sufan Roxana I, McCall Bruce B, Hanley William D, Penuel Elicia M, Pirzkall Andrea, Tabernero Jos |
| Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 9 26 (24): 6559-6567. Stahler Arndt, Stintzing Sebastian, Modest Dominik P, Ricard Ingrid, Giessen-Jung Clemens, Kapaun Christine, Ivanova Boryana, Kaiser Florian, Fischer von Weikersthal Ludwig, Moosmann Nicolas, Schalhorn Andreas, Stauch Martina, Kiani Alexander, Held Swantje, Decker Thomas, Moehler Markus, Neumann Jens, Kirchner Thomas, Jung Andreas, Heinemann Volk |
| Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 4 27 (12): 3422-3431. Williams Christopher J M, Seligmann Jenny F, Elliott Faye, Shires Michael, Richman Susan D, Brown Sarah, Zhang Liping, Singh Shalini, Pugh Judith, Xu Xiao-Meng, Muranyi Andrea, Guetter Christoph, Lorsakul Auranuch, Kurkure Uday, Zhao Zuo, Martin Jim, Wang Xingwei, Nguyen Kien, Liu Wen-Wei, Yan Dongyao, West Nicholas P, Barrett Jennifer H, Barnes Michael, Bai Isaac, Seymour Matthew T, Quirke Philip, Shanmugam Kandav |
| Identification and validation of an immune-relevant risk signature predicting survival outcome and immune infiltration in uveal melanoma. International ophthalmology 2023 9 . Xiao Sun, Qingmin Li, Guijun |
| Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
- Page last reviewed:Feb 1, 2024
- Content source: